These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30634681)

  • 21. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro.
    Chahine N; Nader M; Duca L; Martiny L; Chahine R
    Drug Chem Toxicol; 2016; 39(1):87-96. PubMed ID: 25885550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells.
    Xin H; Liu XH; Zhu YZ
    Eur J Pharmacol; 2009 Jun; 612(1-3):75-9. PubMed ID: 19356731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.
    Wang L; Zhang X; Chan JY; Shan L; Cui G; Cui Q; Wang Y; Li J; Chen H; Zhang Q; Yu P; Han Y; Wang Y; Lee SM
    J Cell Biochem; 2016 Jan; 117(1):94-105. PubMed ID: 26058377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.
    Rharass T; Gbankoto A; Canal C; Kurşunluoğlu G; Bijoux A; Panáková D; Ribou AC
    Mol Cell Biochem; 2016 Feb; 413(1-2):199-215. PubMed ID: 26833193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
    Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen sulfide attenuates doxorubicin‑induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells.
    Liu MH; Zhang Y; Lin XL; He J; Tan TP; Wu SJ; Yu S; Chen L; Chen YD; Fu HY; Yuan C; Li J
    Mol Med Rep; 2015 Oct; 12(4):5197-202. PubMed ID: 26134131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
    Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
    Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells.
    Oliveira MS; Carvalho JL; Campos AC; Gomes DA; de Goes AM; Melo MM
    Toxicol Lett; 2014 Jan; 224(3):380-6. PubMed ID: 24291741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
    Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
    Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells.
    Merten KE; Jiang Y; Kang YJ
    Exp Biol Med (Maywood); 2007 May; 232(5):682-9. PubMed ID: 17463165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspalathin ameliorates doxorubicin-induced oxidative stress in H9c2 cardiomyoblasts.
    Shabalala SC; Dludla PV; Muller CJF; Nxele X; Kappo AP; Louw J; Johnson R
    Toxicol In Vitro; 2019 Mar; 55():134-139. PubMed ID: 30576852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin's Main Metabolites on Cardiac AC16 Cells Versus the Parent Drug.
    Reis-Mendes A; Vitorino-Oliveira C; Ferreira M; Carvalho F; Remião F; Sousa E; de Lourdes Bastos M; Costa VM
    Cardiovasc Toxicol; 2024 Mar; 24(3):266-279. PubMed ID: 38347287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.
    Han R; Sun Y; Kang C; Sun H; Wei W
    J Drug Target; 2017 Feb; 25(2):140-148. PubMed ID: 27356094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
    Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
    Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
    Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
    Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC-MS based non-targeted metabolomic analysis.
    Yi X; Zhu J; Zhang J; Gao Y; Chen Z; Lu S; Cai Z; Hong Y; Wu Y
    J Pharm Biomed Anal; 2018 Apr; 152():264-270. PubMed ID: 29438868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J; Skarka A; Havrankova J; Wsol V
    Biochem Pharmacol; 2015 Aug; 96(3):168-78. PubMed ID: 25986883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species.
    Kazama K; Okada M; Yamawaki H
    Biochem Biophys Res Commun; 2015 Feb; 457(4):602-7. PubMed ID: 25600813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention.
    Nishikawa T; Miyahara E; Kurauchi K; Watanabe E; Ikawa K; Asaba K; Tanabe T; Okamoto Y; Kawano Y
    PLoS One; 2015; 10(6):e0131394. PubMed ID: 26114497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.